RecruitingPhase 3NCT07013487
26
studies recruiting now
as of 7 Sept 2026
319
studies registered in total
as of 7 Sept 2026
13
countries with a recruiting site
as of 7 Sept 2026
16 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT07706686
Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
RecruitingPhase 2NCT06006559
A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
RecruitingNCT07602920
Gut Leakage' in Dengue
RecruitingPhase 2NCT04597437
Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 26 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Dengue fever study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Dengue fever
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
1 approved treatment and 10 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Chimeric Yellow Fever Dengue Virus, Live Attenuated (Dengvaxia)
Phase 2/3Ivermectin (Heartguard)
Phase 2Mosnodenvir
Phase 2Resomelagon
Phase 2Cholecalciferol (Accrete d3)
Phase 2Ic14
Phase 2Melatonin (Circadin)
Phase 2Zanamivir (Relenza)
Phase 1/2Modipafant
+ 2 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).